Our physicians have partnered with Objective GI to create Northeast GI Research Division. The goal is to provide our patients with alternative options to their care.
NASH, or Non-Alcoholic SteatoHepatitis, is an ever-growing health concern in our country today. This silent disease causes liver inflammation and scarring that can lead to cirrhosis, heart and kidney problems, liver cancer, and ultimately death. There are currently no therapeutic treatment options for this condition. Our team strives to find successful studies to provide our patients with efficient and cost-effective options.
Talk to your provider today to see if you qualify for any of our research studies.